Bob Massie has the qualifications and the heart to become a great – maybe even an historically great – US Senator.
And I believe he is the only candidate, announced or rumored, who can defeat that “caboose of the Senate”, Scott Brown.
He believes in the power of our innovative and competitive economic system, but he understands that a successful economy requires and is strengthened by justice and by compassion and by community. He has experienced and appreciates first-hand the promise of innovation and excellence in our healthcare system, but he knows that promise is empty for too many because of spiraling costs driven by misplaced incentives and by systematic waste obscuring our common goal: better health for everybody. He has led the charge to build the business case, and the greater societal case, for energy and environmental sustainability, not just as a moral duty but also as a positive driver for a stronger economy and a better society.
- For twenty years, he has been one of the nation’s strongest advocates for decisive action to avert global climate change.
- His success working hand in hand with corporations to build sustainable business practices provides a blueprint for a new 21st century economy.
- His experience and monitoring of financial markets gives him the business perspective and tools to keep powerful interests aligned with the public interest.
- His personal health history makes him a passionate advocate for high quality and affordable health care for all.
- He is a fierce critic of the Citizen’s United decision allowing corporate contributions to campaigns and will support a constitutional amendment to reverse it.
- His work for the homeless in New York and with the disenfranchised in South Africa sparked his passion to fight for fundamental rights and dignity of every person – no matter their gender, race, age, sexual orientation or disability status.
Find out more about Bob and the campaign at bobmassie.org and about Bob’s background and amazing accomplishments at Wikipedia/Bob_Massie
I’ve spent some considerable time talking with and studying the announced and unannounced candidates. [This is the second most important election in America for 2012!] I’ve come to the conclusion that Bob Massie is the class of the field and can win. Bob is a deeply experienced and thoughtful politician. Except for his now-cured health issues of the past decade, I am sure he would have been Governor or Senator already. He has the values and the savvy to be a Senator, and while not a clone of Kennedy, he shares many of the young Kennedy’s best traits: he listens, he has strong values and he knows what being a Senator is all about (i.e., building to a winning vote total by being the wisest and most convincing person in the room). As an aside, his almost unbelievable struggle against his Job-like health issues has left him with a very nuanced and mature view on the healthcare system; he believes in innovation and has the moral authority tempered with realism to navigate constructive change there.
I went to the MA State Democratic Convention in June and listened to all the announced candidates. There are some fine, accomplished people in the race, and I like a lot of them personally. But there is too little experience, too little credible resolve and too little substance and breadth in the rest of the field. Listen to Bob’s convention speech: Bob_Massie_2011_Dem_Convention. And yes, I’ve considered the several rumored candidates on the sidelines. I know them all. I don’t think some of them want the job or have the demeanor for the job. And I don’t think any have Bob’s tenacity and substance and courage.
So that’s why I’m supporting Bob Massie for the US Senate from Massachusetts. Join me in that effort.
Bob Massie in the Senate would be a powerful force, working for a better future for everyone, a future that is within our reach.
Joshua Boger, Ph.D.
Founder & Director, Vertex Pharmaceuticals Incorporated*
Co-Founder & Co-Chair, Progressive Business Leaders Network (PBLN)*
*Affiliations are for identification purposes only and do not imply institutional endorsement.
